DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC

Institutional investor · Portfolio as of Q1 2026

SEC EDGAR SourceSEC Filings

Top Holdings355 positions

Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
TSMTSM
ADR

TAIWAN SEMICONDUCTOR MANUFAC

1.3M$427.5M3.1%$64.83+569.65%
29 qtrssince 2019-Q1
Decreased
0

PRAXIS PRECISION MEDICINES I

949,225$305.8M2.2%$165.02+96.94%
9 qtrssince 2024-Q1
Increased
54

XENON PHARMACEUTICALS INC

4.5M$261.2M1.9%$28.88+138.68%
25 qtrssince 2020-Q1
Decreased
0

CRINETICS PHARMACEUTICALS IN

6.4M$232.3M1.7%$26.62+213.96%
24 qtrssince 2020-Q2
Increased
48

PLANET LABS PBC

7.9M$221.3M1.6%$9.96+161.66%
4 qtrssince 2025-Q2
Decreased
0

FABRINET

391,081$204M1.5%$404.12+16.58%
4 qtrssince 2025-Q2
Increased
70

APOGEE THERAPEUTICS INC

1.9M$161.7M1.2%$41.31+223.56%
11 qtrssince 2023-Q3
Decreased
0

LUMENTUM HLDGS INC

228,995$160.9M1.2%$94.75+746.45%
4 qtrssince 2025-Q2
Decreased
0

CURTISS WRIGHT CORP

225,759$153.8M1.1%$238.29+216.74%
17 qtrssince 2022-Q1
Decreased
0

CREDICORP LTD

450,730$152.9M1.1%$170.02+135.75%
9 qtrssince 2024-Q1
Decreased
0

FTAI AVIATION LTD

579,521$142M1.0%$52.58+332.42%
13 qtrssince 2023-Q1
Decreased
0

EDGEWISE THERAPEUTICS INC

4.5M$141.1M1.0%$21.19+114.29%
10 qtrssince 2023-Q4
Increased
51

GUARDANT HEALTH INC

1.5M$140.8M1.0%$44.83+257.00%
5 qtrssince 2025-Q1
Decreased
0

SPYRE THERAPEUTICS INC

2.8M$140.8M1.0%$23.40+317.67%
11 qtrssince 2023-Q3
Decreased
0

INTERDIGITAL INC

417,727$126.2M0.9%$289.26-8.43%
4 qtrssince 2025-Q2
Increased
47

NEXTPOWER INC

1M$125.1M0.9%$70.88+57.32%
5 qtrssince 2025-Q1
Increased
53

CARPENTER TECHNOLOGY CORP

315,457$124.3M0.9%$217.13+166.48%
7 qtrssince 2024-Q3
Decreased
0

COHERENT CORP

516,229$123M0.9%$105.90+206.43%
9 qtrssince 2024-Q1
Increased
49

BLOOM ENERGY CORP

849,801$115.1M0.8%$104.84+133.31%
3 qtrssince 2025-Q3
Increased
62

URANIUM ENERGY CORP

8.3M$112.5M0.8%$5.98+75.99%
16 qtrssince 2022-Q2
Decreased
0
Showing 20 of 355 results.335 more with Pro.PROUpgrade to see all →
$13.6B
AUM
355
Positions
Q1 2026
Filing
Rating · 2.0
Quarterly Portfolio Change
+4%Q4'24$12.1B-14%Q1'25$10.4B+20%Q2'25$12.5B+12%Q3'25$14B+5%Q4'25$14.7B-8%Q1'26$13.6B
Activity profile
$ moved · Q1'26
New21%Increased20%Decreased30%Exited29%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.3 years
<1Q10%1-4Q19%1-2Y12%2Y+59%

DRIEHAUS CAPITAL MANAGEMENT LLC manages $13.6B across 355 positions as of Q1 2026. Top holdings: TSM (3.1%), PRAX (2.2%), XENE (1.9%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q1 2026 Summary

Active quarter - 88 new positions, 137 exits, 91 increased. Top move: FN (INCREASED, conviction 70). Portfolio: $13.6B across 355 positions.

Top holdings by portfolio weight

Total AUM$14B
TSM3.14%
PRAX2.25%
XENE1.92%
CRNX1.71%
PL1.63%
FN1.50%
APGE1.19%
LITE1.18%
CW1.13%
BAP1.12%
Other1.04%

Portfolio allocation by GICS sector

Sectors11
Healthcare27.35%
Industrials22.39%
Technology18.03%
Consumer Cyclical7.93%
Energy7.72%
Financial Services6.96%
Basic Materials5.04%
Consumer Defensive2.48%
Unknown0.87%
Communication Services0.68%
Other0.55%

Behavioral investing profile

7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record73
Conviction43
Concentration25
Upgrade to see all dimensions

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
CASYCASEYS GEN STORES INC
Q2 2025 Q1 2026+46,292 shares+$34.2M
4Q
EWTXEDGEWISE THERAPEUTICS INC
Q2 2025 Q1 2026+3.1M shares+$110.8M
4Q
IMAXIMAX CORP
Q2 2025 Q1 2026+1.2M shares+$51.6M

Upgrade to Pro to see all accumulation streaks

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used